ADIPOQ and obesity disorder: The onset of obesity leads to AT remodeling, reducing the release of anti‐inflammatory adipokines (e.g., adiponectin) and increasing the secretion of pro‐inflammatory adipokines (e.g., leptin) [49, 50].